Vibronix Patent Portfolio Analysis

Money arrives ninety-five months after the file

The pulse is dated 14 September 2026: a $14.9M Series B from the National Science Foundation, IDG Capital, Dalton Venture, Frees Fund and Tao Capital. Vibronix was founded in 2014. That is twelve years between incorporation and this round, and the company reached it in the diagnosis and surgery space with one published patent family to its name.

The date that matters more sits eight years earlier. The last filing anybody outside the company can read was lodged on 10 October 2018, ninety-five months before this pulse. Anything drafted since is either unpublished or does not exist, and from the public record the two possibilities look identical. The round is the first loud event in a very quiet file.

Nothing granted, everything still in flight

The split is lopsided in the way early records usually are, except there is only one thing to split. One family, published, pending, filed in the United States. Granted: none. The ribbon on the granted side is not narrow so much as absent, and the whole weight of the record sits on the application side of the line.

That is a statement about timing, not quality. A 2018 priority date puts this family squarely in the window where a first grant becomes plausible, and the first should land around 2026. Until it does, the claims are a proposal rather than a boundary. The published text has been readable for years; what it will finally cover is still being decided.

The whole record is one document, and it has not finished becoming a patent yet.

Two names, and one on everything

Two inventors are named across the record: Yan Xia and Lu Lan. Yan Xia appears on one of one. With a single family there is no distribution to read, no drift of authorship as a team grows, no second cohort arriving in year four. There is a pair of people and a document they wrote together in 2018.

Small inventor sets are not automatically thin. They mean the technical judgement is concentrated, and that the institutional memory of why the claims read as they do lives in two heads. The titles say what the work is: surgical shape sensing fiber optic apparatus and method. Filed once, in one office, and then public silence for eight years.

One circle you have to look for

Set on the same scale as the other organisations filing in these CPC groups over the last five years, Vibronix is the small mark. Cilag Int filed 84 families. Covidien 83. Intuitive Surgical Operations 73. Zeiss Carl Meditec 39, Stryker 33, Alcon 29. Against that, one. The gap is three orders of argument wide and there is no honest way to soften it.

Counting is the wrong instrument here. In a space this densely filed, volume buys coverage but not distinctiveness, and the question for a single-family holder is only ever what the claims actually reach. Breadth on one document can matter more than eighty narrow ones. It also fails more completely if the scope comes back trimmed.

Five readers who left a trace

The lines running back into that one family come from Tsinghua University, twice, and from Zhejiang Lab, Boeing, Intuitive Surgical Operations and Northern Digital once each. Citations are not endorsements and they are not permission. They are evidence that the document was found, read closely enough to be relevant, and placed on the record by someone else's examiner or attorney.

Note who appears on both diagrams. Intuitive Surgical Operations files heavily in these same groups and also cites this family. So does Boeing, which sits outside the medical filers entirely. A 2018 application from two inventors at a company with no grants has travelled further as a reference than its size predicts. That is the interesting part of this file.

Reach, in a record this small, is measured by who had to acknowledge it.

What the next eighteen months decide

Everything behind this question is one document, two names and a date in October 2018. The $14.9M arrived long after the drafting was done, which means the round was priced on something the public record cannot show: either work that remains unpublished, or confidence in what that single family will become when it issues.

The first grant should land around 2026. When it does, the claims will either hold the width the 2018 text reached for, or they will not, and the answer will be readable by anyone. Until then, the strongest fact in the file is that organisations filing at eighty times the volume have already cited it.